BATM Advanced Communications Limited's (LON:BVC) Zvi Marom speaks to Proactive London's Andrew Scott after hiking its full-year revenue and earnings expectations. He says the Bio-Medical division has performed exceptionally well in the first half of 2020, thanks in part to the sale of antigen and antibody testing kits to health authorities as well as the sale of critical care ventilators. Marom adds that things are starting to return to normal too in its Networking & Cyber division as lockdown restrictions are eased around the world.
BATM Advanced Communications 'overwhelmed by demand' for its coronavirus tests
Quick facts: BATM Advanced Communications Ltd
Price: 112.09 GBX
Market Cap: £493.51 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of BATM Advanced Communications Ltd named herein, including the promotion by the Company of BATM Advanced Communications Ltd in any Content on the...FOR OUR FULL DISCLAIMER CLICK HERE